Ocugen Inc Dividends

The next dividend date for Ocugen Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Ocugen Inc (OCGN)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Ocugen Inc

Country
USA
Full Time Employees
95

Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.

Owning Ocugen Inc Stock on the Dividend Date

If you own Ocugen Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Ocugen Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Ocugen Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Ocugen Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Ocugen Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Ocugen Inc Dividends

You can contact us any time if you would like to ask questions about Ocugen Inc dividends or anything else related to the stock market.